The system reads lengths of up to 600 base pairs to drive powerful and cost-effective experiments in multiple areas, including cancer research, inherited disease, and microbial and infectious disease applications.
The digitized development system automates the development of real-time polymerase chain reaction assays, enabling nonprofessionals to develop multiplexed molecular diagnostics.
Laboratories in the United States are now able to perform reproductive testing using the automated anti-Müllerian hormone assay with the company’s Access 2 or DxI immunoassay systems.
NeoGenomics has opened the doors of its new Swiss facility to bring its pharma and esoteric testing services offerings to the global research community.
The study prospectively enrolled 20 stem-cell transplant patients to evaluate the Karius test for diagnosis and monitoring of infections over time.
Grundium is developing a portable digital microscope scanner, to be launched in spring 2018.
FDA has granted market clearance to Memorial Sloan Kettering Cancer Center’s integrated mutation profiling of actionable cancer targets tumor profiling test, an in vitro diagnostic that can identify a greater number of genetic mutations in various cancers than any test previously reviewed by the agency.
Agendia and Institut Curie have announced a covalidation partnership for Agendia’s new in vitro diagnostic MammaPrint BluePrint breast cancer risk of recurrence and molecular subtyping kit.
To find out more about FDA’s recent safety alert and its effects on the clinical laboratory community, CLP recently spoke with Ramani Wonderling, PhD, associate director for scientific relations in diagnostics at Abbott.
A simple buccal swab is collected with the urine sample, and DNA markers from the swab and the urine are matched.
The system enables clinical labs that perform cancer testing via next-generation sequencing to convert genomic insights to targeted therapies quickly.
The cancers that the test screens for—cancers of the breast, colorectum, esophagus, liver, lung, ovary, pancreas, and stomach—account for more than 60% of cancer deaths in the United States.
The sealing performance of the tube makes it suitable for centrifuging samples, while its external thread eliminates the possibility of the sample coming into contact with the screw thread.
The hoods come in 48-, 60-, and 72-inch widths and include a dedicated wash-down and exhaust system.
A new study indicates that adults ages 65 years and older who are hospitalized with fever or respiratory symptoms during influenza season are less likely to have a provider-ordered influenza test than younger patients.
The plate enables scalable and simplified workflows to meet rapidly increasing next-generation sequencing demands for high-throughput and low-input library preparation.
Dry slide technology does not require water, plumbing and drains, or the need to dispose of water as medical waste.
FDA has issued BD a warning letter that cites several violations of federal law, including marketing significantly modified versions of certain BD Vacutainer blood collection tubes without FDA clearance or approval and failing to submit medical device reports within the required timeframe.
The pediatric pharmacogenomic solution and testing panel evaluates seven actionable genes to determine how a pediatric patient will uniquely respond to specific prescription medications, and provides actionable prescribing information for 24 drugs.
The smartphone application supports rapid, remote hemoglobin analysis.